These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2272188)

  • 21. A comparison of a sustained release preparation of tiaprofenic acid with the conventional tablet formulation and a placebo in rheumatoid arthritis.
    Essigman W; Lambert J; Sheldon P; Sweetman BJ; Wojtulewski J
    Int J Clin Pharmacol Res; 1987; 7(4):251-7. PubMed ID: 3596867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double blind comparison of diclofenac and indomethacin in the treatment of ankylosing spondylitis.
    Khan MA
    J Rheumatol; 1987 Feb; 14(1):118-23. PubMed ID: 3553586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis.
    Kornasoff D; Maisenbacher J; Bowdler J; Raber A
    Rheumatol Int; 1996; 15(6):225-30. PubMed ID: 8778950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of flurbiprofen and indomethacin in rheumatoid arthritis.
    Siegmeth W
    Curr Med Res Opin; 1977; 5(1):64-73. PubMed ID: 71973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of different indomethacin formulations in young and elderly patients: a comparative controlled clinical trial.
    Kaarela K; Lehtinen K; Skinhøj A; Andersen F
    Curr Med Res Opin; 1989; 11(7):427-31. PubMed ID: 2673662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac.
    Furst DE; Kolba KS; Fleischmann R; Silverfield J; Greenwald M; Roth S; Hall DB; Roszko PJ;
    J Rheumatol; 2002 Mar; 29(3):436-46. PubMed ID: 11908554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a slow-release indomethacin tablet and naproxen in osteoarthrosis.
    Gordin A; Sotka S; Nuutila J
    Curr Med Res Opin; 1985; 9(7):500-4. PubMed ID: 3896659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diclofenac sodium (Voltaren) and ibuprofen in rheumatoid arthritis. A randomized double-blind study.
    Meinicke J; Danneskiold-Samsøe B
    Scand J Rheumatol Suppl; 1980; 35():1-8. PubMed ID: 7006069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind randomized trial of diclofenac sodium versus placebo in patients with rheumatoid arthritis.
    Weisman MH
    Clin Ther; 1986; 8(4):427-38. PubMed ID: 3524843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diclofenac sodium (Voltaren) and naproxen in the treatment of rheumatoid arthritis: a comparative double-blind study.
    Kajander A; Martio J
    Scand J Rheumatol Suppl; 1978; (22):57-62. PubMed ID: 356247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
    Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE
    Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis.
    Domljan Z; Durrigl T
    Eur J Rheumatol Inflamm; 1983; 6(3):291-6. PubMed ID: 6391934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diclofenac (Voltarol) in rheumatoid arthritis: a report of a double-blind trial.
    Doreen MS; Boardman PL; Fowler PD; Poole PH
    Rheumatol Rehabil; 1979; Suppl 2():78-80. PubMed ID: 394280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Night-time indomethacin in rheumatoid arthritis.
    Carr G; Dougan M; Brooks PM; Maycock S
    Curr Med Res Opin; 1982; 8(3):197-9. PubMed ID: 7128192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.
    Brogden RN; Heel RC; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Jul; 20(1):24-48. PubMed ID: 6772422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and tolerability of controlled-release dihydrocodeine tablets and combination dextropropoxyphene/paracetamol tablets in patients with severe osteoarthritis of the hips.
    Lloyd RS; Costello F; Eves MJ; James IG; Miller AJ
    Curr Med Res Opin; 1992; 13(1):37-48. PubMed ID: 1468244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind comparison of etodolac SR and diclofenac SR in the treatment of patients with degenerative joint disease of the knee.
    Khan FM; Williams PI
    Curr Med Res Opin; 1992; 13(1):1-12. PubMed ID: 1468239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketoprofen versus indomethacin in patients with rheumatoid arthritis: a multicenter double blind comparative study.
    Caldwell JR; Germain BF; Lourie SH; McLaughlin GE; Poiley JE; Vreede PD; Wilson CH
    J Rheumatol; 1988 Oct; 15(10):1476-9. PubMed ID: 3060612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value and results of long-term studies with diclofenac sodium (Voltarol).
    Ciccolunghi SN; Chaudri HA; Schubiger BI
    Rheumatol Rehabil; 1979; Suppl 2():100-15. PubMed ID: 394274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
    Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
    Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.